Clinical trial
A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
NCT01987427
Study timeline
Study start (actual)2013-10-30Date precision: day
Registry last updated2019-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Chronic Weight Managementunresolved
Interventions
Sponsors & collaborators
Eisai Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1DallasTexas, United States1BirminghamAlabama, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1OrlandoFlorida, United States1RichmondVirginia, United States1La JollaCalifornia, United States1NorfolkVirginia, United States1Baton RougeLouisiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01987427 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.